GEDEON RICHTER IBERIAN GEDEON RICHTER GROUP THERAPEUTIC AREAS PRESS HEALTH PROFESSIONALS BEGINNINGPRESSNON-PROFESSIONAL PRESS ROOMGEDEON RICHTER SUPPORTS THE CARLOS III HEALTH INSTITUTE WITH A DONATION FOR RESEARCH PROJECTS ON COVID-19 Gedeon Richter supports the Carlos III Health Institute with a donation for research projects on Covid-19 Madrid , October 2020 .- GEDEON RICHTER, a pharmaceutical company specializing in women's health, has carried out several initiatives to support the care and well-being of people over the years. With this same objective, the Spanish subsidiary of GEDEON RICHTER launched the "EVERY DETAIL COUNTS" Project a few months ago to find a way to contribute, as a Company whose mission is Health, to the efforts that a Foundation or Institution of recognized prestige was developing linked to containing the Covid-19 pandemic and aligned with the mission and values of the Company. Currently there are numerous research projects to study the effects of the pandemic and search for therapies and vaccines to control its spread. Gedeon Richter has wanted to join the efforts that health professionals are carrying out in this field but involving the medical class, who know first-hand the current situation caused by the pandemic, to give their support to an entity to which allocate an economic endowment in the form of a donation. Through an anonymous and voluntary survey, among various options proposed based on its social reputation and alignment with the criteria set out in the project's objectives, the Carlos III Health Institute of Madrid has been the entity chosen by healthcare professionals. El proyecto "CADA DETALLE CUENTA" quiere transmitir el mensaje de que incluso una contribución que por separado podría considerarse modesta, cuando forma parte de un proyecto global puede ser muy apreciable. La donación por parte de GEDEON RICHTER de 30.000€ espera ser una contribución que ayude a seguir desarrollando los valiosos proyectos de investigación que tiene el Instituto de Salud Carlos III en marcha y que estamos seguros empezarán a dar resultados esperanzadores en breve. “Nuestra contribución se realiza en un momento difícil y necesario en el que cualquier apoyo es bueno para para luchar contra el avance de la pandemia. El Instituto de Salud Carlos III de referencia en nuestro país, es el receptor de esta aportación que esperamos contribuya a seguir potenciando los proyectos de investigación que permitan avanzar en la lucha contra el coronavirus”, ha manifestado Miklós Auerbach, Director General de Gedeon Richter Ibérica. ¿DÓNDE ESTAMOS? SEDE CENTRAL OFICINAS BARCELONA UNIDAD DE SALUD DE LA MUJER Pedro i Pons 9-11, 7ª 08034, Barcelona Tel.: +34 93 203 4300 Fax.: +34 93 205 2016 OFICINAS MADRID UNIDAD DE FERTILIDAD María de Molina 41 28006, Madrid Tel.: +34 91 905 1190 FARMACOVIGILANCIA Tel .: (+34) 93 203 43 00 - opc 1 Email: drugsafety.es@gedeonrichter.eu Gedeon Richter Global Site Contact Medical information Links of interest Privacy Policy Legal warning Cookies policy Site Map Copyright © 2020 Gedeon Richter